HUP1800248A2 - Spirochromane derivatives - Google Patents

Spirochromane derivatives

Info

Publication number
HUP1800248A2
HUP1800248A2 HU1800248A HUP1800248A HUP1800248A2 HU P1800248 A2 HUP1800248 A2 HU P1800248A2 HU 1800248 A HU1800248 A HU 1800248A HU P1800248 A HUP1800248 A HU P1800248A HU P1800248 A2 HUP1800248 A2 HU P1800248A2
Authority
HU
Hungary
Prior art keywords
spirochromane
derivatives
spirochromane derivatives
Prior art date
Application number
HU1800248A
Other languages
English (en)
Inventor
Eles Janos Dr
Molnar Katalin Dudasne
Ledneczki Istvan Dr
Tapolcsanyi Pal Dr
Horvath Anita Dr
Nemethy Zsolt Dr
Levay Gyoergy Istvan Dr
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Priority to HUP1800248A priority Critical patent/HU231333B1/hu
Priority to TW108122548A priority patent/TWI821321B/zh
Priority to ES19744868T priority patent/ES2964617T3/es
Priority to EA202190245A priority patent/EA202190245A1/ru
Priority to CU2020000108A priority patent/CU24680B1/es
Priority to GEAP201915557A priority patent/GEP20237534B/en
Priority to PCT/IB2019/055948 priority patent/WO2020012422A1/en
Priority to SG11202012594RA priority patent/SG11202012594RA/en
Priority to MX2021000460A priority patent/MX2021000460A/es
Priority to JP2021500532A priority patent/JP7487167B2/ja
Priority to CA3104258A priority patent/CA3104258A1/en
Priority to US17/259,972 priority patent/US20210330650A1/en
Priority to EP19744868.1A priority patent/EP3820869B1/en
Priority to AU2019300514A priority patent/AU2019300514B2/en
Priority to BR112020026996-4A priority patent/BR112020026996A2/pt
Priority to CN201980046665.7A priority patent/CN112823157A/zh
Priority to HUE19744868A priority patent/HUE064417T2/hu
Priority to ARP190101991A priority patent/AR115782A1/es
Priority to PE2021000053A priority patent/PE20211809A1/es
Priority to KR1020217004264A priority patent/KR20210033002A/ko
Publication of HUP1800248A2 publication Critical patent/HUP1800248A2/hu
Priority to PH12020552183A priority patent/PH12020552183A1/en
Priority to IL279938A priority patent/IL279938A/en
Priority to CL2021000080A priority patent/CL2021000080A1/es
Priority to CONC2021/0001216A priority patent/CO2021001216A2/es
Publication of HU231333B1 publication Critical patent/HU231333B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HUP1800248A 2018-07-13 2018-07-13 Spirokromán származékok HU231333B1 (hu)

Priority Applications (24)

Application Number Priority Date Filing Date Title
HUP1800248A HU231333B1 (hu) 2018-07-13 2018-07-13 Spirokromán származékok
TW108122548A TWI821321B (zh) 2018-07-13 2019-06-27 唍衍生物
US17/259,972 US20210330650A1 (en) 2018-07-13 2019-07-12 Spirochromane derivatives
AU2019300514A AU2019300514B2 (en) 2018-07-13 2019-07-12 Spirochromane derivatives
CU2020000108A CU24680B1 (es) 2018-07-13 2019-07-12 Derivados de espirocromano como moduladores del receptor de acetilcolina nicotínica alfa7
GEAP201915557A GEP20237534B (en) 2018-07-13 2019-07-12 Spirochromane derivatives
PCT/IB2019/055948 WO2020012422A1 (en) 2018-07-13 2019-07-12 Spirochromane derivatives
SG11202012594RA SG11202012594RA (en) 2018-07-13 2019-07-12 Spirochromane derivatives
MX2021000460A MX2021000460A (es) 2018-07-13 2019-07-12 Derivados de espirocromano.
JP2021500532A JP7487167B2 (ja) 2018-07-13 2019-07-12 スピロクロマン誘導体
CA3104258A CA3104258A1 (en) 2018-07-13 2019-07-12 Spirochromane derivatives
ES19744868T ES2964617T3 (es) 2018-07-13 2019-07-12 Derivados del espirocromano
EP19744868.1A EP3820869B1 (en) 2018-07-13 2019-07-12 Spirochromane derivatives
EA202190245A EA202190245A1 (ru) 2018-07-13 2019-07-12 Производные спирохромана
BR112020026996-4A BR112020026996A2 (pt) 2018-07-13 2019-07-12 Composto, uso de composto, método para o tratamento ou prevenção de um transtorno associado à atividade de receptor nicotínico a7 de acetilcolina, composição farmacêutica, combinação, e, processo para fabricação de compostos
CN201980046665.7A CN112823157A (zh) 2018-07-13 2019-07-12 螺色满衍生物
HUE19744868A HUE064417T2 (hu) 2018-07-13 2019-07-12 Spirokromán származékok
ARP190101991A AR115782A1 (es) 2018-07-13 2019-07-12 DERIVADOS DE ESPIROCROMANO, UN MÉTODO PARA SU PREPARACIÓN, INTERMEDIARIOS PARA SU SÍNTESIS, COMPOSICIÓN Y COMBINACIÓN FARMACÉUTICA QUE LOS COMPRENDEN Y EL USO DE LOS MISMOS EN EL TRATAMIENTO DE ENFERMEDADES ASOCIADAS AL RECEPTOR NICOTÍNICO DE ACETILCOLINA a7
PE2021000053A PE20211809A1 (es) 2018-07-13 2019-07-12 Derivados de espirocromano
KR1020217004264A KR20210033002A (ko) 2018-07-13 2019-07-12 스피로크로만 유도체
PH12020552183A PH12020552183A1 (en) 2018-07-13 2020-12-16 Spirochromane derivatives
IL279938A IL279938A (en) 2018-07-13 2021-01-04 History of spirochroman
CL2021000080A CL2021000080A1 (es) 2018-07-13 2021-01-12 Derivados de espirocromano
CONC2021/0001216A CO2021001216A2 (es) 2018-07-13 2021-02-03 Derivados de espirocromano

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUP1800248A HU231333B1 (hu) 2018-07-13 2018-07-13 Spirokromán származékok

Publications (2)

Publication Number Publication Date
HUP1800248A2 true HUP1800248A2 (en) 2020-01-28
HU231333B1 HU231333B1 (hu) 2023-01-28

Family

ID=89992725

Family Applications (2)

Application Number Title Priority Date Filing Date
HUP1800248A HU231333B1 (hu) 2018-07-13 2018-07-13 Spirokromán származékok
HUE19744868A HUE064417T2 (hu) 2018-07-13 2019-07-12 Spirokromán származékok

Family Applications After (1)

Application Number Title Priority Date Filing Date
HUE19744868A HUE064417T2 (hu) 2018-07-13 2019-07-12 Spirokromán származékok

Country Status (23)

Country Link
US (1) US20210330650A1 (hu)
EP (1) EP3820869B1 (hu)
JP (1) JP7487167B2 (hu)
KR (1) KR20210033002A (hu)
CN (1) CN112823157A (hu)
AR (1) AR115782A1 (hu)
AU (1) AU2019300514B2 (hu)
BR (1) BR112020026996A2 (hu)
CA (1) CA3104258A1 (hu)
CL (1) CL2021000080A1 (hu)
CO (1) CO2021001216A2 (hu)
CU (1) CU24680B1 (hu)
EA (1) EA202190245A1 (hu)
ES (1) ES2964617T3 (hu)
GE (1) GEP20237534B (hu)
HU (2) HU231333B1 (hu)
IL (1) IL279938A (hu)
MX (1) MX2021000460A (hu)
PE (1) PE20211809A1 (hu)
PH (1) PH12020552183A1 (hu)
SG (1) SG11202012594RA (hu)
TW (1) TWI821321B (hu)
WO (1) WO2020012422A1 (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202202495A (zh) 2020-03-26 2022-01-16 匈牙利商羅特格登公司 作為ｇａｍｍａ－胺基丁酸Ａ受體次單元ａｌｐｈａ ５受體調節劑之㖠啶及吡啶并〔３，４－ｃ〕嗒𠯤衍生物
CN115403579A (zh) * 2021-05-27 2022-11-29 上海拓界生物医药科技有限公司 一种新的螺环衍生物及其用途
HUP2100338A1 (hu) 2021-09-29 2023-04-28 Richter Gedeon Nyrt GABAA ALFA5 receptor modulátor hatású biciklusos aminszármazékok

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1782811A4 (en) 2004-08-09 2010-09-01 Eisai R&D Man Co Ltd INNOVATIVE ANTIPALUDITIC AGENT CONTAINING A HETEROCYCLIC COMPOUND
JP5341516B2 (ja) 2005-09-13 2013-11-13 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ２−アニリン−４−アリール置換チアゾール誘導体
TW200813067A (en) * 2006-05-17 2008-03-16 Astrazeneca Ab Nicotinic acetylcholine receptor ligands
CN101490056A (zh) * 2006-05-17 2009-07-22 阿斯利康(瑞典)有限公司 烟碱乙酰胆碱受体的配体101
JP2010513495A (ja) 2006-12-20 2010-04-30 シェーリング コーポレイション 新規なｊｎｋ阻害剤
KR101186704B1 (ko) 2007-10-04 2012-09-27 에프. 호프만-라 로슈 아게 테트라졸-치환된 아릴 아마이드 유도체 및 이의 용도
ES2460897T3 (es) 2007-10-04 2014-05-14 F. Hoffmann-La Roche Ag Derivados de ciclopropil aril amida y usos de los mismos
US8536221B2 (en) 2008-02-07 2013-09-17 Abbvie Inc. Amide derivatives as positive allosteric modulators and methods of use thereof
CN102066343B (zh) 2008-03-19 2013-12-04 詹森药业有限公司 作为烟碱乙酰胆碱受体调节剂的三取代1，2，4-三唑类
EP2110377A1 (en) 2008-04-15 2009-10-21 DAC S.r.l. Spirocyclic derivatives as histone deacetylase inhibitors
ES2392795T3 (es) 2008-04-17 2012-12-13 Proximagen Limited Indoles como moduladores del receptor nicotínico de acetilcolina de subtipo alfa-7
WO2009135944A1 (en) 2008-05-09 2009-11-12 Janssen Pharmaceutica Nv Trisubstituted pyrazoles as acetylcholine receptor modulators
JP2011524864A (ja) 2008-05-30 2011-09-08 メルク・シャープ・エンド・ドーム・コーポレイション 新規な置換されたアザベンゾオキサゾール
EP2966075B1 (en) 2009-12-31 2019-02-27 Hutchison Medipharma Limited Certain triazolopyridines, compositions thereof and their use in the treatment of cancer.
US8829026B2 (en) 2010-10-01 2014-09-09 Raqualia Pharma Inc. Sulfamoyl benzoic acid heterobicyclic derivatives as TRPM8 antagonists
JP2016512225A (ja) 2013-03-13 2016-04-25 ルピン・リミテッドＬｕｐｉｎ Ｌｉｍｉｔｅｄ アルファー７ｎａｃｈｒモジュレータとしてのピロール誘導体
GEP20207149B (en) 2016-03-22 2020-09-10 Merck Sharp & Dohme Allosteric modulators of nicotinic acetylcholine receptors
EP3534888B1 (en) 2016-11-01 2022-04-06 Merck Sharp & Dohme Corp. Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors
CA3046805A1 (en) * 2016-12-14 2018-06-21 89Bio Ltd. Spiropiperidine derivatives

Also Published As

Publication number Publication date
EA202190245A1 (ru) 2021-04-20
CA3104258A1 (en) 2020-01-16
JP2021531260A (ja) 2021-11-18
JP7487167B2 (ja) 2024-05-20
EP3820869A1 (en) 2021-05-19
AR115782A1 (es) 2021-02-24
HU231333B1 (hu) 2023-01-28
CU24680B1 (es) 2023-10-06
CN112823157A (zh) 2021-05-18
KR20210033002A (ko) 2021-03-25
TW202035399A (zh) 2020-10-01
GEP20237534B (en) 2023-09-11
WO2020012422A1 (en) 2020-01-16
AU2019300514A1 (en) 2021-02-11
SG11202012594RA (en) 2021-02-25
ES2964617T3 (es) 2024-04-08
PH12020552183A1 (en) 2021-06-21
CL2021000080A1 (es) 2021-10-29
US20210330650A1 (en) 2021-10-28
HUE064417T2 (hu) 2024-03-28
EP3820869B1 (en) 2023-08-30
PE20211809A1 (es) 2021-09-14
AU2019300514B2 (en) 2023-02-02
CU20200108A7 (es) 2021-07-02
BR112020026996A2 (pt) 2021-04-06
MX2021000460A (es) 2021-06-23
IL279938A (en) 2021-03-01
TWI821321B (zh) 2023-11-11
CO2021001216A2 (es) 2021-02-26

Similar Documents

Publication Publication Date Title
DK3467457T3 (en) Vibrationssensor
CA185383S (en) Casque
IL271607B1 (en) New azaquinoline histories
CA185382S (en) Casque
CA185384S (en) Casque
CA185385S (en) Casque
IL283990A (en) Modified oxopyridine derivatives
DK3554057T3 (en) Audioheadsetsystem
DK3613739T3 (en) Integrin-antagonister
IL289197A (en) History of 2-hydroxycycloalkane-1-carbamoyl
CA184991S (en) Uroflowmeter
DK3633783T3 (en) Universal-powerbank
IL279938A (en) History of spirochroman
CA184994S (en) Uroflowmeter
IL290815A (en) History of alpha-d-galactopyranoside
SI3796975T1 (sl) Derivati sulfonilaminobenzamida
IL271290A (en) Dihydro-pyrrolo-pyridine derivatives
HUE062256T2 (hu) Dihidrokromén-származékok
DK3570498T3 (en) Adaptivt hvac-styresystem
SG11202006837XA (en) Dihydroindolizinone derivative
DK3578923T3 (en) Navigationssystem
GB201806948D0 (en) Derivatives
GB201919210D0 (en) Dihydro-cyclopenta-isoquinoline derivatives
DK3542617T3 (en) Etikette
AU201817245S (en) MC-Roller